TrialInternational journal of chronic obstructive pulmonary disease2016

Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.

Stephen I Rennard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.